CN1532182A - 大叶蒟有效部位的制备及其在医疗、保健领域的应用 - Google Patents
大叶蒟有效部位的制备及其在医疗、保健领域的应用 Download PDFInfo
- Publication number
- CN1532182A CN1532182A CNA031159117A CN03115911A CN1532182A CN 1532182 A CN1532182 A CN 1532182A CN A031159117 A CNA031159117 A CN A031159117A CN 03115911 A CN03115911 A CN 03115911A CN 1532182 A CN1532182 A CN 1532182A
- Authority
- CN
- China
- Prior art keywords
- effective part
- preparation
- extract
- part extract
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000746610 Piper laetispicum Species 0.000 title claims abstract 5
- 238000002360 preparation method Methods 0.000 title claims description 10
- 238000013160 medical therapy Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 239000011347 resin Substances 0.000 claims abstract description 8
- 229920005989 resin Polymers 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 16
- 229930013930 alkaloid Natural products 0.000 claims description 10
- -1 amide alkaloid Chemical class 0.000 claims description 10
- 239000003463 adsorbent Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 5
- 208000024732 dysthymic disease Diseases 0.000 claims description 5
- 208000017194 Affective disease Diseases 0.000 claims description 4
- 208000019022 Mood disease Diseases 0.000 claims description 4
- QMIWSRNEYNUYFE-WKOVGYJXSA-N N-Isobutyldeca-trans-2-trans-4-dienamide Natural products O=C(N[C@@H](CC)C)/C=C/C=C/CCCCC QMIWSRNEYNUYFE-WKOVGYJXSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 4
- MAGQQZHFHJDIRE-UHFFFAOYSA-N pellitorine Natural products CCCCCC=CC=CC(=O)NCC(C)C MAGQQZHFHJDIRE-UHFFFAOYSA-N 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 claims description 3
- MAGQQZHFHJDIRE-BNFZFUHLSA-N pellitorine Chemical compound CCCCC\C=C\C=C\C(=O)NCC(C)C MAGQQZHFHJDIRE-BNFZFUHLSA-N 0.000 claims description 3
- 208000020016 psychiatric disease Diseases 0.000 claims description 3
- MAGQQZHFHJDIRE-QNRZBPGKSA-N (2E,4Z)-N-Isobutyl-2,4-decadienamide Chemical compound CCCCC\C=C/C=C/C(/O)=N/CC(C)C MAGQQZHFHJDIRE-QNRZBPGKSA-N 0.000 claims description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- MAGQQZHFHJDIRE-VVKPDYKWSA-N cis-pellitorine Natural products C(C(C)C)NC(\C=C\C=CCCCCC)=O MAGQQZHFHJDIRE-VVKPDYKWSA-N 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- QFQYZMGOKIROEC-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC=C2OCOC2=C1 QFQYZMGOKIROEC-UHFFFAOYSA-N 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 1
- 239000000287 crude extract Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 claims 1
- 238000007670 refining Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 230000008451 emotion Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000001519 thymoleptic effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- RTHCYVBBDHJXIQ-UHFFFAOYSA-N N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine Chemical compound C=1C=CC=CC=1C(CCNC)OC1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 229940035613 prozac Drugs 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000007598 dipping method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XZTCTKKANUDQCW-QHHAFSJGSA-N (2E)-Piperamide-C5:1 Chemical compound C=1C=C2OCOC2=CC=1CC/C=C/C(=O)N1CCCC1 XZTCTKKANUDQCW-QHHAFSJGSA-N 0.000 description 1
- BFZBGTMIBOQWBA-HRCSPUOPSA-N 1-[(2E,4E)-2,4-decadienoyl]pyrrolidine Chemical compound CCCCC\C=C\C=C\C(=O)N1CCCC1 BFZBGTMIBOQWBA-HRCSPUOPSA-N 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000013210 evaluation model Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BFZBGTMIBOQWBA-UHFFFAOYSA-N iyeremide A Natural products CCCCCC=CC=CC(=O)N1CCCC1 BFZBGTMIBOQWBA-UHFFFAOYSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- XZTCTKKANUDQCW-UHFFFAOYSA-N piperamine Natural products C=1C=C2OCOC2=CC=1CCC=CC(=O)N1CCCC1 XZTCTKKANUDQCW-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031159117A CN100436407C (zh) | 2003-03-20 | 2003-03-20 | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031159117A CN100436407C (zh) | 2003-03-20 | 2003-03-20 | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1532182A true CN1532182A (zh) | 2004-09-29 |
CN100436407C CN100436407C (zh) | 2008-11-26 |
Family
ID=34284491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031159117A Expired - Lifetime CN100436407C (zh) | 2003-03-20 | 2003-03-20 | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100436407C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006058487A1 (fr) | 2004-12-01 | 2006-06-08 | Ezhou Wang | Extrait de piper laetispicum c.dc., procédé d'élaboration et applications |
CN102240281A (zh) * | 2010-05-12 | 2011-11-16 | 天津天士力制药股份有限公司 | 5′-甲氧基-3′,4′-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 |
CN102429962A (zh) * | 2010-09-29 | 2012-05-02 | 王全福 | 大叶蒟提取物的制备方法、提取物及其应用 |
CN102475746A (zh) * | 2010-11-23 | 2012-05-30 | 天津天士力制药股份有限公司 | 大叶蒟有效组分的制备方法 |
CN102850317A (zh) * | 2011-06-27 | 2013-01-02 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
CN103063789A (zh) * | 2011-10-19 | 2013-04-24 | 天士力制药集团股份有限公司 | 同时检测大叶蒟中12个酰胺类生物碱的液相分析方法 |
CN107837301A (zh) * | 2017-11-01 | 2018-03-27 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
CN107884488A (zh) * | 2017-11-01 | 2018-04-06 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物、药材及其相关产品中抗抑郁有效成分的含量测定方法 |
CN112107606A (zh) * | 2020-11-05 | 2020-12-22 | 陈乃宏 | 香青藤或其提取物在制备抗抑郁药物中的用途 |
CN112156134A (zh) * | 2020-10-29 | 2021-01-01 | 健民药业集团股份有限公司 | 大叶蒟提取物用于制备透明质酸酶抑制剂的用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1137702C (zh) * | 2000-07-14 | 2004-02-11 | 复旦大学 | 中草药大叶蒟乙酸乙酯抽提物在制备精神类药物中的应用 |
CN1389462A (zh) * | 2002-07-12 | 2003-01-08 | 复旦大学 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
-
2003
- 2003-03-20 CN CNB031159117A patent/CN100436407C/zh not_active Expired - Lifetime
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1829582A1 (en) * | 2004-12-01 | 2007-09-05 | Ezhou Wang | An extractive of piper laetisipicum c.dc., its process and its uses |
CN100356940C (zh) * | 2004-12-01 | 2007-12-26 | 蒋毅 | 制备大叶蒟提取物的方法、提取物及其应用 |
JP2008521839A (ja) * | 2004-12-01 | 2008-06-26 | 王厄舟 | 大葉(叶)蒟抽出物の調製方法、抽出物及びその応用 |
EP1829582A4 (en) * | 2004-12-01 | 2009-07-29 | Ezhou Wang | EXTRACT OF PIPER LAETISIPICUM C.DC., HIS PROCESS AND ITS APPLICATIONS |
US8062678B2 (en) | 2004-12-01 | 2011-11-22 | Ezhou Wang | Extractive of Piper laetispicum C.DC., its process and its uses |
WO2006058487A1 (fr) | 2004-12-01 | 2006-06-08 | Ezhou Wang | Extrait de piper laetispicum c.dc., procédé d'élaboration et applications |
CN102240281A (zh) * | 2010-05-12 | 2011-11-16 | 天津天士力制药股份有限公司 | 5′-甲氧基-3′,4′-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 |
WO2011140981A1 (zh) * | 2010-05-12 | 2011-11-17 | 天津天士力制药股份有限公司 | 5'-甲氧基-3',4'-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 |
CN102429962A (zh) * | 2010-09-29 | 2012-05-02 | 王全福 | 大叶蒟提取物的制备方法、提取物及其应用 |
CN102475746B (zh) * | 2010-11-23 | 2015-05-06 | 天士力制药集团股份有限公司 | 大叶蒟有效组分的制备方法 |
CN102475746A (zh) * | 2010-11-23 | 2012-05-30 | 天津天士力制药股份有限公司 | 大叶蒟有效组分的制备方法 |
RU2587668C2 (ru) * | 2011-06-27 | 2016-06-20 | Тасли Фармасьютикал Груп Ко., Лтд. | Производное замещенного циннамамида, способ его получения и применения |
US10071989B2 (en) | 2011-06-27 | 2018-09-11 | Tasly Pharmaceutical Group Co., Ltd. | Substituted cinnamamide derivative, preparation method and use thereof |
CN103687850A (zh) * | 2011-06-27 | 2014-03-26 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
WO2013000399A1 (zh) * | 2011-06-27 | 2013-01-03 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
KR101861656B1 (ko) * | 2011-06-27 | 2018-05-28 | 타슬리 파마슈티컬 그룹 컴퍼니 리미티드 | 치환된 신남아미드 유도체, 이의 제조방법 및 용도 |
CN102850317A (zh) * | 2011-06-27 | 2013-01-02 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
AU2012276114B2 (en) * | 2011-06-27 | 2016-08-04 | Tasly Pharmaceutical Group Co., Ltd. | Substituted cinnamamide derivative, preparation method and use thereof |
CN102850317B (zh) * | 2011-06-27 | 2017-02-08 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
CN103063789B (zh) * | 2011-10-19 | 2016-06-08 | 天士力制药集团股份有限公司 | 同时检测大叶蒟中12个酰胺类生物碱的液相分析方法 |
CN103063789A (zh) * | 2011-10-19 | 2013-04-24 | 天士力制药集团股份有限公司 | 同时检测大叶蒟中12个酰胺类生物碱的液相分析方法 |
CN107837301B (zh) * | 2017-11-01 | 2021-05-28 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
CN107884488A (zh) * | 2017-11-01 | 2018-04-06 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物、药材及其相关产品中抗抑郁有效成分的含量测定方法 |
CN107884488B (zh) * | 2017-11-01 | 2019-05-03 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物、药材及其相关产品中抗抑郁有效成分的含量测定方法 |
WO2019085847A1 (zh) * | 2017-11-01 | 2019-05-09 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
JP2021501211A (ja) * | 2017-11-01 | 2021-01-14 | スーゾー イーファー バイオメディカルテクノロジー コーポレーション | 大葉蒟抽出物、及びその調製方法と応用 |
CN107837301A (zh) * | 2017-11-01 | 2018-03-27 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
EP3705128A4 (en) * | 2017-11-01 | 2021-07-07 | Suzhou Yi-hua Biomedical Technology Co., Ltd. | PIPER LAETISPICUM EXTRACT AND METHOD FOR ITS PREPARATION AND USE |
CN113209165A (zh) * | 2017-11-01 | 2021-08-06 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
JP7212051B2 (ja) | 2017-11-01 | 2023-01-24 | スーゾー イーファー バイオメディカルテクノロジー コーポレーション | 大葉蒟抽出物、及びその調製方法と応用 |
US11571453B2 (en) | 2017-11-01 | 2023-02-07 | Suzhou Yi-Hua Biomedical Technology Co., Ltd | Piper laetispicum extract and preparation method therefor and use thereof |
CN112156134A (zh) * | 2020-10-29 | 2021-01-01 | 健民药业集团股份有限公司 | 大叶蒟提取物用于制备透明质酸酶抑制剂的用途 |
CN112107606A (zh) * | 2020-11-05 | 2020-12-22 | 陈乃宏 | 香青藤或其提取物在制备抗抑郁药物中的用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100436407C (zh) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1532182A (zh) | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 | |
CN109820932A (zh) | 一种防治老年痴呆的中药标准汤剂 | |
KR19980014498A (ko) | 부자-유황 복합제제 | |
CN100356940C (zh) | 制备大叶蒟提取物的方法、提取物及其应用 | |
CN1594247A (zh) | 红豆杉属植物提取物和该提取物的提取方法及其应用 | |
CN1733131A (zh) | 五味子提取物,其制备方法及其用途 | |
CN110772610B (zh) | 一种植物提取物及其制备方法和应用 | |
CN102949535A (zh) | 一种抗高血脂及动脉粥样硬化的中药制剂及其制备方法 | |
CN108926561A (zh) | 非洲防己碱在防治痴呆或改善记忆类产品中的应用 | |
CN1541700A (zh) | 从植物槌果藤实中提取抗关节炎有效部位的方法 | |
CN1149989C (zh) | 黄芩茎叶总黄酮及其野黄芩甙作为制备抗痴呆病药的应用 | |
CN1365979A (zh) | 有效成份苦杏仁苷的提取、分离及精制方法 | |
CN1137702C (zh) | 中草药大叶蒟乙酸乙酯抽提物在制备精神类药物中的应用 | |
CN1660352A (zh) | 一种具有协同作用的药物组合物 | |
CN102008577B (zh) | 一种防治苯丙胺类和阿片类药物依赖的药物 | |
CN1977840A (zh) | 银杏内酯配伍药物组合物及其制备方法和用途 | |
CN1445227A (zh) | 夏天无总生物碱的提取方法及其新的用途 | |
CN104130232B (zh) | 一种egcg的提纯方法及获得的egcg和药物组合物 | |
CN1371744A (zh) | 银杏叶缓释片及制备方法 | |
CN104857042A (zh) | 积雪草总苷在制备预防或治疗老年痴呆症的药物中的应用 | |
CN104739949A (zh) | 用于帕金森氏病的组合物及其制备方法 | |
CN1439648A (zh) | 枇杷叶总三萜酸组分及其在制备抗炎、止咳药物中的应用 | |
CN1490014A (zh) | 芒果总甙制剂及其生产方法 | |
CN102389435A (zh) | 伪酸枣仁苷元在制备抗老年痴呆药物中的应用 | |
CN1090968C (zh) | 一种镇痛、镇静药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI KAIRUN BIOMEDICAL CO. LTD Free format text: FORMER OWNER: HAITIAN MEDICINE SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD., SHANGHAI Effective date: 20050325 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050325 Address after: Shanghai city GuoShouJing Road No. 351 Building No. 2 room 678-09 Applicant after: SHANGHAI KAIRUN BIO-PHARMACEUTICAL Co.,Ltd. Address before: Shanghai city Ruijin road Haixing Plaza No. 1 16A Applicant before: Shanghai Haitian Medical Technology Development Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JIANG YI Free format text: FORMER OWNER: SHANGHAI KAIRUN BIOMEDICAL CO. LTD Effective date: 20080613 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080613 Address after: Shanghai city of Yokohama Road 206 Lane 5 Building Room 301 post encoding: 200081 Applicant after: Jiang Yi Address before: Shanghai city GuoShouJing Road No. 351 Building No. 2 room 678-09 post encoding: 201203 Applicant before: SHANGHAI KAIRUN BIO-PHARMACEUTICAL Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU YIHUA BIOMEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIANG YI Effective date: 20150403 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200081 HONGKOU, SHANGHAI TO: 215123 SUZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150403 Address after: Xinghu Street Industrial Park of Suzhou city in Jiangsu province 215123 No. 218 BioBAY A2 building room 230-230A Patentee after: Suzhou Yihua biological medicine technology Limited by Share Ltd. Address before: 200081 Shanghai City Yokohama Road 206 Lane 5 Building Room 301 Patentee before: Jiang Yi |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190111 Address after: No. 107, No. 2 Building, 918 Lane, Wenshui East Road, Hongkou District, Shanghai, 2004 Patentee after: Shanghai Yiling Investment Management Consulting Co.,Ltd. Address before: Room 230-230A, A2 Floor, Bio-nano Park, 218 Xinghu Street, Suzhou Industrial Park, Jiangsu Province Patentee before: Suzhou Yihua biological medicine technology Limited by Share Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190902 Address after: No. 107, No. 2 Building, 918 Lane, Wenshui East Road, Hongkou District, Shanghai, 2004 Patentee after: Shanghai Yihua Biopharmaceutical Co.,Ltd. Address before: No. 107, No. 2 Building, 918 Lane, Wenshui East Road, Hongkou District, Shanghai, 2004 Patentee before: Shanghai Yiling Investment Management Consulting Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220831 Address after: 200434 room 107, building 2, Lane 918, Wenshui East Road, Hongkou District, Shanghai Patentee after: Shanghai Yida Biopharmaceutical Co.,Ltd. Address before: 200434 room 107, building 2, Lane 918, Wenshui East Road, Hongkou District, Shanghai Patentee before: Shanghai Yihua Biopharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20081126 |
|
CX01 | Expiry of patent term |